Matthew E. Levison

25.2k total citations · 8 hit papers
141 papers, 14.8k citations indexed

About

Matthew E. Levison is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Matthew E. Levison has authored 141 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 53 papers in Infectious Diseases and 42 papers in Pharmacology. Recurrent topics in Matthew E. Levison's work include Antibiotics Pharmacokinetics and Efficacy (40 papers), Antibiotic Resistance in Bacteria (35 papers) and Antimicrobial Resistance in Staphylococcus (35 papers). Matthew E. Levison is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (40 papers), Antibiotic Resistance in Bacteria (35 papers) and Antimicrobial Resistance in Staphylococcus (35 papers). Matthew E. Levison collaborates with scholars based in United States, France and Canada. Matthew E. Levison's co-authors include Kathryn A. Taubert, Ann F. Bolger, Michael H. Gewitz, Larry M. Baddour, Jane W. Newburger, Donald Kaye, Walter R. Wilson, Stanford T. Shulman, Robert S. Baltimore and Thomas J. Pallasch and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Matthew E. Levison

140 papers receiving 13.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

2015 1.9k citations Larry M. Baddour, Walter R. Wilson et al. Circulation profile →
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

2004 1.4k citations Jane W. Newburger, Masato Takahashi et al. Circulation profile →
Infective Endocarditis

2005 1.2k citations Larry M. Baddour, Walter R. Wilson et al. Circulation profile →
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association

2004 990 citations Jane W. Newburger, Masato Takahashi et al. profile →
Prevention of bacterial endocarditis. Recommendations by the American Heart Association

1997 776 citations Kathryn A. Taubert, Walter R. Wilson et al. profile →
Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association?

2012 770 citations Peter B. Lockhart, Ann F. Bolger et al. Circulation profile →
Update on Cardiovascular Implantable Electronic Device Infections and Their Management

2010 700 citations Larry M. Baddour, Andrew E. Epstein et al. Circulation profile →
Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association

2016 302 citations Walter R. Wilson, Patrick T. O’Gara et al. Circulation profile →

Peers

Countries citing papers authored by Matthew E. Levison

Since Specialization

Citations

This map shows the geographic impact of Matthew E. Levison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Levison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Levison more than expected).

Fields of papers citing papers by Matthew E. Levison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Levison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Levison. The network helps show where Matthew E. Levison may publish in the future.

Co-authorship network of co-authors of Matthew E. Levison

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew E. Levison. A scholar is included among the top collaborators of Matthew E. Levison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew E. Levison. Matthew E. Levison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications breakdown → 2015 ·Circulation ·Larry M. Baddour, Walter R. Wilson, Arnold S. Bayer, Vance G. Fowler, Imad M. Tleyjeh, Michael J. Rybak, Bruno Baršić, Peter B. Lockhart, Michael H. Gewitz, Matthew E. Levison, Ann F. Bolger, James M. Steckelberg, Robert S. Baltimore, Anne Fink, Patrick T. O’Gara, Kathryn A. Taubert	1919
2	Community-acquired culture-negative endocarditis: clinical characteristics and risk factors for mortality 2014 ·International Journal of Infectious Diseases ·Rinaldo Focaccia Siciliano, Alfredo José Mansur, Jussara Bianchi Castelli, (unknown), Max Grinberg, Matthew E. Levison, Tânia Mara Varejão Strabelli	19
3	Treatment of Complicated Urinary Tract Infections With an Emphasis on Drug-Resistant Gram-Negative Uropathogens 2013 ·Current Infectious Disease Reports ·Matthew E. Levison, Donald Kaye	70
4	Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association? breakdown → 2012 ·Circulation ·Peter B. Lockhart, Ann F. Bolger, Panos N. Papapanou, Olusegun Osinbowale, Maurizio Trevisan, Matthew E. Levison, Kathryn A. Taubert, Jane W. Newburger, Heather L. Gornik, Michael H. Gewitz, Walter R. Wilson, Sidney C. Smith, Larry M. Baddour	770
5	A Summary of the Update on Cardiovascular Implantable Electronic Device Infections and Their Management 2011 ·The Journal of the American Dental Association ·Larry M. Baddour, Andrew E. Epstein, Christopher C. Erickson, Bradley P. Knight, Matthew E. Levison, Peter B. Lockhart, Frederick A. Masoudi, Eric Okum, Walter R. Wilson, Lee B. Beerman, Ann F. Bolger, N.A. Mark Estes, Michael H. Gewitz, Jane W. Newburger, Eleanor Schron, Kathryn A. Taubert	18
6	Update on Cardiovascular Implantable Electronic Device Infections and Their Management breakdown → 2010 ·Circulation ·Larry M. Baddour, Andrew E. Epstein, Christopher C. Erickson, Bradley P. Knight, Matthew E. Levison, Peter B. Lockhart, Frederick A. Masoudi, Eric Okum, Walter R. Wilson, Lee B. Beerman, Ann F. Bolger, N.A. Mark Estes, Michael H. Gewitz, Jane W. Newburger, Eleanor Schron, Kathryn A. Taubert	700
7	Community-associated methicillin-resistant Staphylococcus aureus: Reconsideration of therapeutic options 2006 ·Current Infectious Disease Reports ·Matthew E. Levison, (unknown)	8
8	Infective Endocarditis breakdown → 2005 ·Circulation ·Larry M. Baddour, Walter R. Wilson, Arnold S. Bayer, Vance G. Fowler, Ann F. Bolger, Matthew E. Levison, Patricia Ferrieri, Michael A. Gerber, Lloyd Y. Tani, Michael H. Gewitz, David Tong, James M. Steckelberg, Robert S. Baltimore, Stanford T. Shulman, Jane C. Burns, Donald A. Falace, Jane W. Newburger, Thomas J. Pallasch, Masato Takahashi, Kathryn A. Taubert	1204
9	Plasmid-mediated extended-spectrum β-lactamases in organisms other than Klebsiella pneumoniae and Escherichia coli: A hidden reservoir of transferable resistance genes 2002 ·Current Infectious Disease Reports ·Matthew E. Levison	6
10	Unique Features of Infective Endocarditis in Childhood 2002 ·Circulation ·Patricia Ferrieri, Michael H. Gewitz, Michael A. Gerber, Jane W. Newburger, Adnan S. Dajani, Stanford T. Shulman, Walter R. Wilson, Ann F. Bolger, Arnold S. Bayer, Matthew E. Levison, Thomas J. Pallasch, Tommy W. Gage, Kathryn A. Taubert	176
11	Regional Occurrence of Plasmid‐Mediated SHV‐7, an Extended‐Spectrum β‐Lactamase, inEnterobacter cloacaein Philadelphia Teaching Hospitals 2002 ·Clinical Infectious Diseases ·Matthew E. Levison, (unknown), (unknown), George A. Jacoby, Pamela S. Adams, Christopher L. Emery, (unknown), P. G. Pitsakis	22
12	Anaerobic pleuropulmonary infection 2001 ·Current Opinion in Infectious Diseases ·Matthew E. Levison	9
13	Collaborative Multidisciplinary Workshop Report: Detection, Culture, Serology, and Antimicrobial Susceptibility Testing ofChlamydia pneumoniae 2000 ·The Journal of Infectious Diseases ·Lucy S. Tompkins, Julius Schachter, Jens Boman, Scott F. Dowell, Charlotte A. Gaydos, Matthew E. Levison, Matthias Maass, Guillermo Madico, J Orfila, Kazunobu Ouchi, Rosanna Ŵ. Peeling, D Taylor‐Robinson, Walter E. Stamm, (unknown), Francesco Blasi, David A. Relman	18
14	Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association 1997 ·Clinical Infectious Diseases ·Adnan S. Dajani, Kathryn A. Taubert, Walter R. Wilson, Ann F. Bolger, Arnold S. Bayer, Patricia Ferrieri, Michael H. Gewitz, Stanford T. Shulman, Soraya Nouri, Jane W. Newburger, (unknown), Thomas J. Pallasch, Tommy W. Gage, Matthew E. Levison, Georges Peter, Gregory Zuccaro	116
15	An Assessment of the Usefulness of the Duke Criteria for Diagnosing Active Infective Endocarditis 1997 ·Clinical Infectious Diseases ·Mikkael A. Sekeres, Elías Abrutyn, Jesse A. Berlin, Donald Kaye, Judith L. Kinman, Oksana M. Korzeniowski, Matthew E. Levison, Roy S. Feldman, Brian L. Strom	52
16	Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula 1995 ·Journal of Antimicrobial Chemotherapy ·Christine Cole Johnson, Lawrence L. Livornese, (unknown), P. G. Pitsakis, Sharon K. Taylor, Matthew E. Levison	28
17	Incidence of infective endocarditis in the Delaware Valley, 1988–1990 1995 ·The American Journal of Cardiology ·Jesse A. Berlin, Elías Abrutyn, Brian L. Strom, Judith L. Kinman, Matthew E. Levison, Oksana M. Korzeniowski, Roy S. Feldman, Donald Kaye	120
18	Synergistic Bactericidal Activity of Rat Serum with Vancomycin against Enterococci 1991 ·The Journal of Infectious Diseases ·(unknown), (unknown), Michaela Wendeler, Matthew E. Levison, Christine Cole Johnson	13
19	Host Defense Mechanisms in the Pathogenesis of Urinary Tract Infection 1991 ·Medical Clinics of North America ·(unknown), Matthew E. Levison	20
20	Epidemiology of Asymptomatic Bacteriuria in Elderly Women 1991 ·Journal of the American Geriatrics Society ·Elías Abrutyn, Jana Mossey, Matthew E. Levison, Jerome A. Boscia, P. G. Pitsakis, Donald Kaye	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact